Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Marco Fuel"'
Autor:
Marco Fuel, Cristina Mesas, Rosario Martínez, Raúl Ortiz, Francisco Quiñonero, Francisco Bermúdez, Natalia Gutiérrez, Ana M. Torres, Garyfallia Kapravelou, Aída Lozano, Gloria Perazzoli, Jose Prados, Jesús M. Porres, Consolación Melguizo
Publikováno v:
Antioxidants, Vol 11, Iss 12, p 2421 (2022)
Legumes are a highly nutritious source of plant protein, fiber, minerals and vitamins. However, they also contain several bioactive compounds with significant potential benefits for human health. The objectives of this study were to evaluate the anti
Externí odkaz:
https://doaj.org/article/9d7a9e579ec541f6b457da947f26887f
Autor:
Marco Fuel, Rosario Martínez, Cristina Mesas, Jesús M. Porres, Jose Prados, Consolación Melguizo
Publikováno v:
Critical Reviews in Food Science and Nutrition. 62:6293-6314
Colon cancer is the fourth leading cause of cancer deaths around the world. Despite advances in understanding its etiology and in diagnosis and treatment, new therapeutic strategies are still required. In this sense, the Solanaceae and Cucurbitaceae
Autor:
Cristina, Mesas, Marco, Fuel, Rosario, Martínez, Jose, Prados, Consolación, Melguizo, Jesús M, Porres
Publikováno v:
Critical reviews in food science and nutrition. 62(23)
Colon cancer is the fourth leading cause of cancer deaths around the world. Despite advances in understanding its etiology and in diagnosis and treatment, new therapeutic strategies are still required. In this sense, the
Autor:
Cristina Mesas, Francisco Quiñonero, Consolación Melguizo, Marco Fuel, Raúl Ortiz, Beatriz García-Pinel, Jose Prados, Laura Cabeza
Publikováno v:
Cancers, Vol 13, Iss 2058, p 2058 (2021)
Digibug: Repositorio Institucional de la Universidad de Granada
Universidad de Granada (UGR)
Cancers
Digibug. Repositorio Institucional de la Universidad de Granada
instname
Digibug: Repositorio Institucional de la Universidad de Granada
Universidad de Granada (UGR)
Cancers
Digibug. Repositorio Institucional de la Universidad de Granada
instname
The development of drug resistance is one of the main causes of cancer treatment failure. This phenomenon occurs very frequently in different types of cancer, including colon and pancreatic cancers. However, the underlying molecular mechanisms are no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1858c007df030766b40cacc305f46ba7
http://hdl.handle.net/10481/69329
http://hdl.handle.net/10481/69329
Publikováno v:
Química Central Ciencia y Naturaleza; Vol. 6 Núm. 1 (2017): Química Central; 11-19
Revista Química central
Universidad Central del Ecuador
instacron:UCE
Revista Química central
Universidad Central del Ecuador
instacron:UCE
The objective of the research was to evaluate how useful is the amylase and serum lipase in the diagnosis and controlof treatment of patients with acute abdominal pancreatic and non-pancreatic pain who attended at NORTHOSPITALHospital in Quito during
Publikováno v:
Molecular Cancer Therapeutics. 20:P074-P074
Introduction Resistance to cyclin inhibitors such as palbociclib is a challenge in the treatment of hormone-dependent metastatic breast cancer. Likewise, triple negative tumors are resistant to these inhibitors. The role of the present research is to
Autor:
Jose Prados, Cristina Mesas, Consolación Melguizo, Francisco Quiñonero, Marco Fuel, Jesús M. Porres, Rosario Martínez, Raúl Ortiz
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 143, Iss, Pp 112248-(2021)
Digibug. Repositorio Institucional de la Universidad de Granada
Consorcio Madroño
Digibug. Repositorio Institucional de la Universidad de Granada
Consorcio Madroño
This research was funded by the CTS-107 and AGR145 Groups from the Granada University. M. Fuel obtained all plants of the study from Ecuador. A part of this study has been funded by the 2018 Research Initiation Grants Program for Master Students of t
Autor:
Consolación Melguizo, Raquel Luque, Cristina Mesas, Gloria Perazzoli, M.J. Gandara, Kevin Doello, Marco Fuel, Raúl Ortiz, R. Garcıá-Fumero, C. García-Collado, Jose Prados
Publikováno v:
Annals of Oncology. 30:v16
Background Cabazitaxel is used in the treatment of metastatic prostate cancer. It is not a substrate of P-glycoprotein, which is involved in cellular detoxification of chemotherapeutic agents and in the expulsion of drugs at blood-brain barrier. Our